Manulife (Manufacturers Life Insurance) Portfolio holdings
AUM
$112B
1-Year Return
19.76%
This Quarter Return
-1.97%
1 Year Return
+19.76%
3 Year Return
+56.91%
5 Year Return
+121.6%
10 Year Return
+261.3%
AUM
$106B
AUM Growth
-$9.48B
(-8.2%)
Cap. Flow
-$6.18B
Cap. Flow
% of AUM
-5.85%
Top 10 Holdings %
Top 10 Hldgs %
20.53%
Holding
3,030
New
58
Increased
1,261
Reduced
1,513
Closed
133
Top Buys
| 1 |
Adobe
ADBE
|
+$314M |
| 2 |
Lennar Class A
LEN
|
+$296M |
| 3 |
Amgen
AMGN
|
+$187M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$164M |
| 5 |
PACCAR
PCAR
|
+$163M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$758M |
| 2 |
Gilead Sciences
GILD
|
+$402M |
| 3 |
Walmart
WMT
|
+$378M |
| 4 |
Royal Bank of Canada
RY
|
+$362M |
| 5 |
Aon
AON
|
+$343M |
Sector Composition
| 1 | Technology | 21.63% |
| 2 | Financials | 15.67% |
| 3 | Healthcare | 12.31% |
| 4 | Consumer Discretionary | 10.21% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
WM Technology
MAPS
$132M
| $33K | ﹤0.01% |
29,174
+3,589
| +14% | +$4.06K |
|
2827
Destination XL Group
DXLG
$69.5M
| $30.8K | ﹤0.01% |
21,072
-618
| -3% | -$902 |
|
2828
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $30.5K | ﹤0.01% |
37,848
-55
| -0.1% | -$44 |
|
2829
MacroGenics
MGNX
$111M
| $30.4K | ﹤0.01% |
23,914
-97,112
| -80% | -$123K |
|
2830
Holley
HLLY
$451M
| $30.1K | ﹤0.01% |
11,713
-234
| -2% | -$601 |
|
2831
iRobot
IRBT
$106M
| $30K | ﹤0.01% |
11,125
-11
| -0.1% | -$30 |
|
2832
Fate Therapeutics
FATE
$111M
| $29.3K | ﹤0.01% |
37,096
-1,307
| -3% | -$1.03K |
|
2833
scPharmaceuticals
SCPH
$300M
| $28.9K | ﹤0.01% |
+11,004
| New | +$28.9K |
|
2834
Cardlytics
CDLX
$48.5M
| $28.7K | ﹤0.01% |
15,751
+638
| +4% | +$1.16K |
|
2835
Pliant Therapeutics
PLRX
$107M
| $28.7K | ﹤0.01% |
21,223
-53,603
| -72% | -$72.4K |
|
2836
Sight Sciences
SGHT
$193M
| $28.5K | ﹤0.01% |
11,866
-1,978
| -14% | -$4.75K |
|
2837
Caribou Biosciences
CRBU
$169M
| $28.4K | ﹤0.01% |
31,076
-2,535
| -8% | -$2.32K |
|
2838
Energy Vault
NRGV
$312M
| $28.1K | ﹤0.01% |
40,416
+1,121
| +3% | +$780 |
|
2839
Ventyx Biosciences
VTYX
$170M
| $27.3K | ﹤0.01% |
23,753
+258
| +1% | +$297 |
|
2840
Tango Therapeutics
TNGX
$758M
| $26.6K | ﹤0.01% |
19,438
+142
| +0.7% | +$195 |
|
2841
PLAYSTUDIOS Inc
MYPS
$121M
| $25.9K | ﹤0.01% |
20,378
-255
| -1% | -$324 |
|
2842
Chegg
CHGG
$168M
| $23.7K | ﹤0.01% |
37,154
-636
| -2% | -$407 |
|
2843
Biomea Fusion
BMEA
$111M
| $22.9K | ﹤0.01% |
10,743
+236
| +2% | +$503 |
|
2844
Renovaro
RENB
$51.3M
| $21.2K | ﹤0.01% |
38,941
-6,856
| -15% | -$3.72K |
|
2845
Cassava Sciences
SAVA
$103M
| $21K | ﹤0.01% |
13,998
-944
| -6% | -$1.42K |
|
2846
Sutro Biopharma
STRO
$83.3M
| $20.2K | ﹤0.01% |
30,993
+112
| +0.4% | +$73 |
|
2847
Black Diamond Therapeutics
BDTX
$185M
| $15.6K | ﹤0.01% |
+10,062
| New | +$15.6K |
|
2848
Rekor Systems
REKR
$153M
| $14.2K | ﹤0.01% |
+16,066
| New | +$14.2K |
|
2849
Atossa Therapeutics
ATOS
$104M
| $12.8K | ﹤0.01% |
19,020
-27,311
| -59% | -$18.4K |
|
2850
Invivyd
IVVD
$255M
| $9.74K | ﹤0.01% |
+16,093
| New | +$9.74K |
|